Jason A. Dominitz
Executive Director, National Gastroenterology and Hepatology Program, Veterans Health Administration Gastroenterology
Division of Gastroenterology

Faculty Information

Jason Dominitz, M.D., is a board-certified gastroenterologist, Executive Program Director for Gastroenterology and Hepatology for the US Department of Veterans Health Affairs and a UW Professor of Gastroenterology and Medicine.
As Executive Director for Gastroenterology and Hepatology at the VA, Dr. Dominitz leads over one thousand VA gastroenterologists and hepatologists across the nation and has created new programs for colonoscopy quality assurance. Dr. Dominitz is a nationally recognized leader in the field of colorectal cancer screening, serving on the US Multi-Society Task Force on Colorectal Cancer and as the VA representative to the National Colorectal Cancer Round Table. He is Co-Chair of a VA research study comparing screening colonoscopy to annual stool-based screening for colorectal cancer in over 50,000 Veterans. 
Dr. Dominitz has devoted his career to ensuring that all individuals have access to high-quality gastrointestinal care through his national VA leadership, research, and service on professional societies. He is passionate about providing each of his patients with comprehensive and compassionate care to improve their quality of life. He values taking time to make sure that they understand their health conditions, as well as diagnostic and treatment options.
Dr. Dominitz graduated from Johns Hopkins University and earned his M.D. from the University of Maryland. He has published more than 250 peer-reviewed publications, guidelines, and editorials on the clinical practice of Gastroenterology. Dr. Dominitz is a member of the American Society for Gastrointestinal Endoscopy (ASGE) Quality in Endoscopy Committee and formerly served as a counselor on the ASGE Governing Board and as chair of the ASGE Standards of Practice Committee and the ASGE Research Committee. He also serves as a member of the Gastroenterology Devices Panel of the FDA Center for Devices and Radiologic Health. Dr. Dominitz is currently an Associate Editor for Gastroenterology and formerly was the Senior Associate Editor for the American Journal of Gastroenterology and an Associate Editor for Gastrointestinal Endoscopy.

Board Certifications:

  • Gastroenterology, 2017, American Board of Internal Medicine
Education & Training: 
Fellowship in Gastroenterology
Duke University Medical Center
Fellowship in Health Services Research
Durham Veteran's Medical Center
Masters Degree in Health Sciences in Clinical Research
Duke University Medical School
Residency in Internal Medicine
Duke University Medical Center
Internship in Internal Medicine
Duke University Medical Center
Medical Education
University of Maryland School of Medicine
Bachelor of Arts
Johns Hopkins University
Research & Clinical Interests
Clinical Interests: 
  • Gastroenterology (Digestive)
  • Colorectal Cancer Screening

Selected Publications: 

1.    Patel SC, May FP, Anderson JC, Burke CA, Dominitz JA, Gross SA, Jacobson BC, Shaukat A, Robertson DJ. Updates on age to start and stop colorectal cancer screening: recommendation from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2022;162:285-299. PMID 34794816

2.    Shaukat A, Kaltenbach T, Dominitz JA, Robertson DJ, Anderson JC, Cruise M, Burke CA, Gupta S, Lieberman D, Syngal S, Rex DK. Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2020;159:1916-1934. PMID 33159840.

3.    Kaltenbach T, Gawron A, Meyer CS, Gupta S, Shergill A, Dominitz JA, et al. Adenoma detection rate (ADR) irrespective of indication is comparable to screening ADR: implications for quality monitoring. Clin Gastroenterol Hepatol. 2021 Feb 19:S1542-3565(21)00206-8. PMID: 33618027.

4.    Gupta S, Lieberman D, Anderson JC, Burke CA, Dominitz JA, Kaltenbach T, Robertson DJ, Shaukat A, Syngal S, Rex DK. Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastrointestinal Endoscopy 2020;91(3):463-485.e5. doi: 10.1016/j.gie.2020.01.014. PMID: 32044106.

5.    Dominitz JA, Levin TR. What is organized screening and what is its value? Gastrointestinal Endoscopy Clinics of North America 2020;30(3):393-411. PMID 32439078.

6.    Gupta S, Coronado GD, Argenbright K, Brenner AT, Castañeda SF, Dominitz JA, et al. Mailed Fecal Immunochemical Test Outreach for Colorectal Cancer Screening: Summary of a Centers for Disease Control and Prevention–Sponsored Summit. CA Cancer J Clin.2020;70:283-298. PMID 32583884.

7.    Ladabaum U, Dominitz JA, Kahi C, Schoen RE. Strategies for colorectal cancer screening. Gastroenterology 2020;158(2):418-432. doi: 10.1053/j.gastro.2019.06.043. PMID 31394083.

8.    Beste LA, Ioannou GN, Chang MF, Forsberg CW, Korpak AM, Sporleder JL, Smith NL, Maynard C, Chartier M, Dominitz JA. Cooperative Study Group #488. Prevalence of hepatitis B virus exposure in the Veterans Health Administration and association with military-related risk factors. Clinical Gastroenterology and Hepatology 2019. doi: 10.1016/j.cgh.2019.07.056. PMID 31394284.  

9.    Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017; Jun 2. pii: S0016-5085(17)35599-3. doi: 10.1053/j.gastro.2017.05.013. PMID 27769517.

10.          Robertson DJ, Lee JK, Boland CR, Dominitz JA, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017;112(7):1016-1030. PMID: 28555630.

11.          Dominitz JA, Robertson DJ, Ahnen DJ, et al. for the CONFIRM Study Group. Colonoscopy versus fecal immunochemical test in reducing mortality from colorectal cancer (CONFIRM): Rational for study design. Am J Gastroenterol 2017 Oct 10. doi: 10.1038/ajg.2017.286. PMID 29016565.

12.          Rizk MK, Sawhney MS, Cohen J, Pike IM, Adler DG, Dominitz JA, Lieb JG 2nd, Lieberman DA, Park WG, Shaheen NJ, Wani S. Quality indicators common to all GI endoscopic procedures. American Journal of Gastroenterology 2015;110:48-59. PMID 25448874.

13.          Johnson DA, Barkun AN, Cohen LB, Dominitz JA, et al. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2014;147(4):903-24. PMID 25239068.

14.          Ko CW, Dominitz JA, Nederilak M, Polissar N, Green P, Kreuter W, Baldwin LM.  Determination of colonoscopy indication from administrative claims data. Medical Care 2014;52(4):e21-e29. PMID 22437619.

15.          Dominitz JA, Baldwin LM, Green P, Kreuter W, Ko CW. Regional variation in anesthesia assistance during outpatient colonoscopy is not associated with differences in polyp detection or complication rates. Gastroenterology 2013;144(2):298-306. PMID 23103615.

16.          Lin OS, Kozarek RA, Gluck M, Jiranek GC, Kock J, Kowdley KV, Irani S, Nguyen M, Dominitz JA. Preference for colonoscopy versus computerized tomographic colonography: a systematic review and meta-analysis of observational studies. J Gen Intern Med. 2012;27:1349-60. PMID 22700393.

17.          Lin OS, Kozarek RA, Arai A, Gluck M, Jiranek GC, Kowdley KV, McCormick SE, Schembre DB, Soon M-S, Dominitz JA. The effect of periodic monitoring and feedback on screening colonoscopy withdrawal times, polyp detection rates, and patient satisfaction scores. Gastrointestinal Endoscopy 2010;71:1253-9. PMID 20598251.

18.          Ko CW, Dominitz JA, Green P, et al. Specialty differences in polyp detection, removal and biopsy during colonoscopy. American J Med 2010;123:528-35. PMID 20569759.

19.          Lin OS, Kozarek RA, Schembre DB, Ayub K, Gluck M, Cantone N, Soon MS, Dominitz JA. Risk stratification for colon neoplasia: screening strategies using colonoscopy and computerized tomographic colonography. Gastroenterology 2006;131:1011-9. PMID 17030171.

20.          Dominitz JA, Boyko EJ, Koepsell TD, Heagerty PJ, Maynard C, Sporleder JL, VA Cooperative Study Group 488. Elevated prevalence of hepatitis C infection in users of United States Veterans Medical Centers. Veterans Affairs Cooperative Study Group 488. Hepatology 2005;41(1):88-96. PMID 15619249.

21.          Dominitz JA, Provenzale D.  Patient preferences and quality of life associated with colorectal cancer screening.  Am J of Gastroenterology 1997;92:2171-8. PMID 9399747.